Clinical Trial Update: Maximizing trEatment of Neurological Dysfunction Using INtravenous Guanfacine Study [Phase 2]

View source ↗

Summary

Phase 2 trial conducted at Vanderbilt University Medical Center evaluated intravenous guanfacine for delirium and cognitive impairment in critically ill patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Critical Illness
• Delirium

Drugs mentioned

• Guanfacine (guanfacine)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Critical Illness, Delirium | Phase 2 | Status: COMPLETED | Results posted: 2025-05-06